Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Department of Urology, University of Kansas Hospital, Kansas City, KS, USA.
Eur Urol. 2018 Aug;74(2):134-137. doi: 10.1016/j.eururo.2018.02.024. Epub 2018 Mar 12.
Up to 50% of patients recur after salvage radiation therapy (sRT) for prostate-specific antigen (PSA) rise following radical prostatectomy (RP). Notably, the importance of lymph node dissection (LND) at the time of RP with regard to recurrence risk following sRT has not been previously determined. Therefore, we evaluated the association between nodal yield at RP and recurrence after sRT. We performed a multi-institutional review of men with a rising PSA after RP treated with sRT. Clinicopathologic variables were abstracted, and the associations between lymph node yield and biochemical (BCR) as well as clinical recurrence (CR) after sRT were assessed using multivariable Cox proportional hazards regression models. In total, 728 patients were identified; of these, 221 and 116 were diagnosed with BCR and CR, respectively, during a median follow-up of 8.4 (interquartile range: 4.2-11.2) yr. On multivariable analysis, the risk of BCR after sRT was inversely associated with the number of nodes resected at RP (hazards ratio [HR]: 0.98; 95% confidence interval [CI]: 0.96-0.99; p=0.049). Increased extent of dissection was also independently associated with a decreased risk of CR after sRT (HR: 0.97; 95%CI: 0.94-0.99; p=0.042). These data support the importance of an extensive LND at surgery and may be used in prognosis assessment when sRT is being considered.
We found that patients who had increased number of lymph nodes resected at surgery had improved outcomes after the receipt of salvage radiation therapy. These findings support the use of the extended lymph node dissection at initial surgery and should serve to improve counseling among patients who require salvage radiation therapy.
在根治性前列腺切除术 (RP) 后前列腺特异性抗原 (PSA) 升高行挽救性放疗 (sRT) 后,多达 50%的患者会复发。值得注意的是,RP 时行淋巴结清扫术 (LND) 对 sRT 后复发风险的重要性尚未得到先前确定。因此,我们评估了 RP 时淋巴结切除数量与 sRT 后复发之间的关联。我们对接受 sRT 治疗的 RP 后 PSA 升高的男性进行了多机构回顾。提取了临床病理变量,并使用多变量 Cox 比例风险回归模型评估了淋巴结切除数量与生化 (BCR) 以及 sRT 后临床复发 (CR) 之间的关联。共确定了 728 例患者;其中,221 例和 116 例患者在中位随访 8.4 年 (四分位距:4.2-11.2 年) 期间分别被诊断为 BCR 和 CR。多变量分析显示,sRT 后 BCR 的风险与 RP 时切除的淋巴结数量呈负相关 (风险比 [HR]:0.98;95%置信区间 [CI]:0.96-0.99;p=0.049)。扩大的解剖范围也与 sRT 后 CR 的风险降低独立相关 (HR:0.97;95%CI:0.94-0.99;p=0.042)。这些数据支持在手术时进行广泛的 LND 的重要性,并且当考虑 sRT 时可以用于预后评估。
我们发现手术时切除的淋巴结数量增加的患者在接受挽救性放疗后结局得到改善。这些发现支持在初始手术中使用扩大的淋巴结清扫术,并应有助于改善需要挽救性放疗的患者的咨询。